HIF1A and neoplasm: Therefore, our exploration of SELENOP as a potential biomarker for predicting Ragnum hypoxia scores aligns with the imperative to identify robust markers capable of informing therapeutic strategies and patient outcomes in the context of tumour hypoxia, thereby complementing the established role of HIF1A.